WORK Medical Establishes Nevada U.S. Subsidiary to Enhance Global Distribution and Compliance
WOK•WORK Medical Technology Group established a Nevada-incorporated U.S. subsidiary, Work Bio Technologies Ltd (EIN 42-2095406), as its primary U.S. operational platform to manage supply chains and develop direct business relationships. The move aims to integrate U.S. product distribution, enhance regulatory compliance and bolster global market expansion efforts.
1. Establishment of U.S. Subsidiary
On June 3, 2026, WORK Medical Technology Group formed a wholly owned U.S. subsidiary, Work Bio Technologies Ltd, in Nevada (Entity ID E56873592026-7; EIN 42-2095406) to serve as its primary operational platform for U.S. activities.
2. Strategic Objectives
The subsidiary will manage supply-chain operations, facilitate direct commercial relationships in the U.S., integrate product distribution and customer engagement, enhance regulatory compliance capabilities and support further expansion into key global markets.
3. Corporate Structure and Leadership
Work Bio Technologies Ltd is 100% owned by WORK Medical Technology Group. Mr. Wu Shuang, CEO and Chairman of the parent company, also serves as President, Secretary, Treasurer and Director of the new U.S. entity.
